ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,921,000 | +40.3% | 68,532 | -3.2% | 0.07% | +41.2% |
| Q2 2021 | $8,499,000 | +37.8% | 70,828 | +40.3% | 0.05% | +37.8% |
| Q1 2021 | $6,167,000 | +39.1% | 50,497 | +41.9% | 0.04% | +32.1% |
| Q4 2020 | $4,435,000 | +136.0% | 35,588 | +107.1% | 0.03% | +100.0% |
| Q3 2020 | $1,879,000 | +74.1% | 17,184 | +68.2% | 0.01% | +75.0% |
| Q2 2020 | $1,079,000 | -8.6% | 10,214 | -14.0% | 0.01% | -27.3% |
| Q1 2020 | $1,181,000 | -34.9% | 11,872 | -43.5% | 0.01% | -21.4% |
| Q4 2019 | $1,815,000 | +76.7% | 21,031 | -14.1% | 0.01% | +75.0% |
| Q3 2019 | $1,027,000 | -3.8% | 24,484 | -4.3% | 0.01% | -11.1% |
| Q2 2019 | $1,068,000 | -14.6% | 25,579 | -8.5% | 0.01% | -10.0% |
| Q1 2019 | $1,251,000 | +29.8% | 27,969 | +14.8% | 0.01% | +25.0% |
| Q4 2018 | $964,000 | -21.0% | 24,369 | +1.2% | 0.01% | -20.0% |
| Q3 2018 | $1,220,000 | – | 24,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |